Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Leukotriene and respiratory syncytial virus].

Zhang WX, Li CC.

Zhonghua Er Ke Za Zhi. 2013 Feb;51(2):109-10. Review. Chinese. No abstract available.

PMID:
23527973
2.

Montelukast in respiratory syncytial virus postbronchiolitis.

López-Andreu JA, Cortell-Aznar I, Ruiz-García V.

Am J Respir Crit Care Med. 2004 Jun 1;169(11):1255; author reply 1255-6. No abstract available.

PMID:
15161615
3.

Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?

Szefler SJ, Simoes EA.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):290-1. No abstract available.

PMID:
12554617
4.

Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.

Peng WS, Chen X, Yang XY, Liu EM.

Pediatr Allergy Immunol. 2014 Mar;25(2):143-50. doi: 10.1111/pai.12124. Epub 2013 Oct 7. Review.

PMID:
24118637
5.

A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.

Bisgaard H; Study Group on Montelukast and Respiratory Syncytial Virus.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):379-83. Epub 2002 Oct 3.

PMID:
12406832
6.

Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity.

Khoshoo V, Ross G, Edell D.

Pediatr Infect Dis J. 2002 May;21(5):468-72. Review. No abstract available.

PMID:
12150194
7.

Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.

Bisgaard H, Flores-Nunez A, Goh A, Azimi P, Halkas A, Malice MP, Marchal JL, Dass SB, Reiss TF, Knorr BA.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):854-60. doi: 10.1164/rccm.200706-910OC. Epub 2008 Jun 26.

PMID:
18583576
8.

Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.

Bonville CA, Rosenberg HF, Domachowske JB.

Antiviral Res. 2006 Feb;69(2):53-9. Epub 2005 Nov 28.

PMID:
16337014
9.

[Leukotriene receptor antagonist effective in chronic asthma].

Jébrak G.

Presse Med. 1998 Nov 14;27(35):1795. French. No abstract available.

PMID:
9850698
10.

Montelukast in childhood asthma.

Mehta PN.

Indian Pediatr. 2000 Nov;37(11):1201-9. No abstract available.

PMID:
11086302
11.

Montelukast in RSV-bronchiolitis.

Bisgaard H.

Am J Respir Crit Care Med. 2004 Feb 15;169(4):542-3. No abstract available.

PMID:
14766663
12.

[Importance of leukotriene antagonists in asthma therapy raised].

[No authors listed]

MMW Fortschr Med. 2008 Mar 27;150(13):44-5. German. No abstract available.

PMID:
18522358
13.

[Churg-Strauss syndrome in an asthmatic man treated with montelukast: continued controversy].

Pérez de Llano LA, Veres Racamonde A, Parra Arrondo A.

Arch Bronconeumol. 2002 May;38(5):251. Spanish. No abstract available.

14.

Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.

Currie GP, Lee DK, Menzies D, Lipworth BJ.

Chest. 2006 Jul;130(1):301-2. No abstract available.

PMID:
16840420
15.

Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases.

Ng DK, Law AK, Chau KW, Chan HK.

Respirology. 2000 Dec;5(4):389-92.

PMID:
11192552
16.
17.

Role of leukotrienes and leukotriene receptor antagonists in asthma.

Jones TR, Rodger IW.

Pulm Pharmacol Ther. 1999;12(2):107-10. Review. No abstract available.

PMID:
10373391
18.

[The role of leukotrienes in inflammation and leukotriene inhibitors].

Kupczyk M, Kuna P.

Pol Merkur Lekarski. 1999 Sep;7(39):85-93. Review. Polish.

PMID:
10598480
19.
20.

Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.

Schäper C, Noga O, Koch B, Ewert R, Felix SB, Gläser S, Kunkel G, Gustavus B.

J Investig Allergol Clin Immunol. 2011;21(1):51-8.

Items per page

Supplemental Content

Write to the Help Desk